Home › B-Cell Lymphoma › New Jersey
B-Cell Lymphoma clinical trials in New Jersey
10 studies for B-Cell Lymphoma are looking for participants at sites in New Jersey.
Cities in New Jersey
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
- Rutgers Cancer Institute of New Jersey, New Brunswick
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT07101328A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
- Hackensack, Hackensack
- Atlantic Health, Morristown
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT07188558Study of NX-5948 in Combination With Other Agents in Adults With B-cell Malignancies
- New Jersey Cancer Care, Belleville
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Nov 3, 2026 · NCT07520006A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)
- The Valley Hospital, Inc, Paramus
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 29, 2026 · NCT06742996A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies
- Research Site, Hackensack
- Research Site, New Brunswick
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Oct 28, 2026 · NCT06564038A Study of ARV-393 in Relapsed/Refractory Non-Hodgkin Lymphoma.
- Clinical Trial Site, New Brunswick
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 4, 2026 · NCT06393738Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
- John Theurer Cancer Center Hackensack University Medical Center, Hackensack
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Aug 25, 2026 · NCT05826535Mosunetuzumab With Lenalidomide Augmentation as First-line Therapy for Follicular and Marginal Zone Lymphoma
- Rutgers Cancer Institute of New Jersey, New Brunswick
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 20, 2026 · NCT04792502SynKIR-310 for Relapsed/Refractory B-NHL
- Rutgers Cancer Institute, New Brunswick
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Apr 14, 2026 · NCT06544265Study Evaluating UCART20x22 in B-Cell Non-Hodgkin Lymphoma
- Rutgers Cancer Institute of New Jersey (CINJ) - New Brunswick, New Brunswick
RecruitingPhase 1/2
Ages 18 to 80 · All sexes · Updated Aug 24, 2025 · NCT05607420From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.